GLENMARK PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of GLENMARK for the last quarter is 32.44 B INR, and it's 5.92% higher compared to the previous quarter. The net income of Q1 24 is 3.40 B INR.